◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

CSPC Pharmaceutical Group Limited (1093) Financial History

Name: CSPC Pharmaceutical Group Limited (1093) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-10

CSPC Pharmaceutical Group Limited (1093) operates in the Drug Manufacturers - General industry and is headquartered in Shijiazhuang, China with about 19,700 employees. Its market capitalization is roughly CNY 98 billion. In the fiscal year ended 2025-12-31, 1093 reported CNY 26.0B in revenue and CNY 3.9B in net income.

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

Interactive charts & full statements →

1093 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 26.0B	CNY 29.0B	CNY 31.5B	CNY 30.9B	—
Gross Profit	CNY 17.1B	CNY 20.3B	CNY 22.2B	CNY 22.3B	—
Operating Income (EBIT)	CNY 4.2B	CNY 5.5B	CNY 7.0B	CNY 6.8B	—
Net Income	CNY 3.9B	CNY 4.3B	CNY 5.9B	CNY 6.1B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1093 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 2.5B)	(CNY 3.2B)	(CNY 2.7B)	(CNY 2.1B)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1093 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 46.7B	CNY 44.4B	CNY 46.3B	CNY 41.8B	—
Total Liabilities	CNY 12.1B	CNY 10.5B	CNY 11.3B	CNY 10.1B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1093 viewer.

Other Companies in Drug Manufacturers - General

4503 · Astellas Pharma Inc. — $4.24 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
GSK · GSK plc — $73 billion
4552 · JCR Pharmaceuticals Co., Ltd. — $62 billion
BAYN · Bayer Aktiengesellschaft — $47 billion
2630 · Vigonvita Life Sciences Co., Ltd. — $20 billion

← 1091 All “0-9” companies 1094 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.